BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 28467527)

  • 1. Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry.
    Beohar N; Doshi D; Thourani V; Jensen H; Kodali S; Zhang F; Zhang Y; Davidson C; McCarthy P; Mack M; Kapadia S; Leon M; Kirtane A
    JAMA Cardiol; 2017 Jul; 2(7):742-749. PubMed ID: 28467527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement.
    Witberg G; Steinmetz T; Landes U; Pistiner Hanit R; Green H; Goldman S; Vaknin-Assa H; Codner P; Perl L; Rozen-Zvi B; Kornowski R
    JAMA Netw Open; 2021 Mar; 4(3):e213296. PubMed ID: 33769507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial.
    Anjan VY; Herrmann HC; Pibarot P; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani VH; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    JAMA Cardiol; 2016 Aug; 1(5):584-92. PubMed ID: 27437665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Renal Dysfunction on Results of Transcatheter Aortic Valve Replacement Outcomes in a Large Multicenter Cohort.
    Codner P; Levi A; Gargiulo G; Praz F; Hayashida K; Watanabe Y; Mylotte D; Debry N; Barbanti M; Lefèvre T; Modine T; Bosmans J; Windecker S; Barbash I; Sinning JM; Nickenig G; Barsheshet A; Kornowski R
    Am J Cardiol; 2016 Dec; 118(12):1888-1896. PubMed ID: 27726854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.
    Arnold SV; Spertus JA; Vemulapalli S; Li Z; Matsouaka RA; Baron SJ; Vora AN; Mack MJ; Reynolds MR; Rumsfeld JS; Cohen DJ
    JAMA Cardiol; 2017 Apr; 2(4):409-416. PubMed ID: 28146260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.
    Fukui M; Gupta A; Abdelkarim I; Sharbaugh MS; Althouse AD; Elzomor H; Mulukutla S; Lee JS; Schindler JT; Gleason TG; Cavalcante JL
    JAMA Cardiol; 2019 Mar; 4(3):215-222. PubMed ID: 30725109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke.
    Makkar RR; Yoon SH; Leon MB; Chakravarty T; Rinaldi M; Shah PB; Skipper ER; Thourani VH; Babaliaros V; Cheng W; Trento A; Vemulapalli S; Kapadia SR; Kodali S; Mack MJ; Tang GHL; Kaneko T
    JAMA; 2019 Jun; 321(22):2193-2202. PubMed ID: 31184741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Kidney Recovery in Patients Who Underwent Transcatheter Versus Surgical Aortic Valve Replacement (from the Northern New England Cardiovascular Disease Study Group).
    Lahoud R; Butzel DW; Parsee A; Huang YL; Solomon RJ; DeVries JT; Flynn JM; Iribarne A; Lee PV; Ross CS; Malenka DJ; Dauerman HL
    Am J Cardiol; 2020 Mar; 125(5):788-794. PubMed ID: 31924319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
    Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
    Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Thourani VH; Forcillo J; Beohar N; Doshi D; Parvataneni R; Ayele GM; Kirtane AJ; Babaliaros V; Kodali S; Devireddy C; Szeto W; Herrmann HC; Makkar R; Ailawadi G; Lim S; Maniar HS; Zajarias A; Suri R; Tuzcu EM; Kapadia S; Svensson L; Condado J; Jensen HA; Mack MJ; Leon MB
    Ann Thorac Surg; 2016 Oct; 102(4):1172-80. PubMed ID: 27592092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.
    Douglas PS; Hahn RT; Pibarot P; Weissman NJ; Stewart WJ; Xu K; Wang Z; Lerakis S; Siegel R; Thompson C; Gopal D; Keane MG; Svensson LG; Tuzcu EM; Smith CR; Leon MB
    J Am Soc Echocardiogr; 2015 Feb; 28(2):210-7.e1-9. PubMed ID: 25455544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
    Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
    Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.